Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
February 05, 2024 at 09:19 AM EST
Catalent is the main supplier of fill-finish work, which involves filling and packaging syringes and injection pens, for Novo Nordisk's Wegovy.
